Feature | August 27, 2012

A new? study indicates the CT coronary artery calcium score is the superior test for accurately predicting cardiovascular risk and disease in adults at intermediate risk for heart disease


August 27, 2012 - A recent multi-center study, led by researchers from Wake Forest School of Medicine and published in the Journal of the American Medical Association (JAMA) has indicated that computed tomography (CT) scanning of the heart and measuring the coronary artery calcium (CAC) score is the most accurate predictor of cardiovascular disease for individuals at intermediate risk for heart disease.

The study included 1,300 individuals with intermediate cardiovascular risk factors (excluding diabetes) based on the Framingham Risk Score (FRS), who were followed over a period of seven years as part of the National Heart, Lung and Blood Institute's Multi-Ethnic Study of Atherosclerosis (MESA). MESA is an observational study of cardiovascular disease performed at six sites across the United States.
 
Six novel or established markers of heart disease risk were directly compared. These included the CT CAC score, ankle-brachial index, brachial flow mediated dilation, carotid intima-media thickness, high sensitivity C-reactive protein and family history of heart disease. CAC score, determined by CT scan, held the highest predictive association for cardiovascular disease.
 
According to Jeffery J. Carr, M.D., MSc, a co-author on the publication and president-elect of the Society of Cardiovascular Computed Tomography (SCCT), "This work demonstrates that the calcium score outperforms these widely studied tests and even family history in the prediction of future heart attacks and cardiovascular death. For healthcare providers, we have the first direct comparison of these tests. This new evidence will help in advising our patients when additional information is needed to refine an individual's risk of heart disease. In many cases, no additional testing is needed; however, for those important cases where refining our understanding of risk of heart disease is critical to medical decision-making, the cardiac CT measured calcium score is a clear winner as relates to future risk for an individual."
 
Although CAC scans indicated the highest level of accuracy in predicting cardiovascular risk, factors such as cost and the level of risk due to radiation exposure from CT scan will be future considerations in research.
 
For more information, visit www.SCCT.org
 


Related Content

News | Radiology Imaging | UC San Diego Health

Oct. 16, 2025 — A strategic collaboration between UC San Diego Health and GE HealthCare will focus on bringing advanced ...

Time October 20, 2025
arrow
News | Mammography

Sept. 3, 2025 — According to ARRS’ American Journal of Roentgenology (AJR), a commercial artificial intelligence (AI) ...

Time September 09, 2025
arrow
News | Focused Ultrasound Therapy

Aug. 26, 2025 — In a quest for ever-more-effective treatments for pancreatic cancer, HonorHealth Research Institute is ...

Time August 29, 2025
arrow
News | Lung Imaging

Aug. 26, 2025 — Optellum, a global leader in AI for lung health, recently announced the world’s first thorax CT ...

Time August 26, 2025
arrow
News | RSNA

Aug. 13, 2025 — Registration is now open for the RSNA 111th Scientific Assembly and Annual Meeting, the world’s leading ...

Time August 13, 2025
arrow
News | Artificial Intelligence

July 22, 2025 — GE HealthCare has topped a U.S. Food and Drug Administration (FDA) list of AI-enabled medical device ...

Time July 23, 2025
arrow
News | Breast Imaging

QT Imaging Holdings, Inc. has announced the launch of its latest QTviewer, version 2.8. QTviewer stores and displays the ...

Time July 21, 2025
arrow
News | PET-CT

June 19, 2025 — Building on a collaboration that spans more than three decades, GE HealthCare has renewed its research ...

Time June 19, 2025
arrow
News | Cardiac Imaging

April 30, 2025 – Viz.ai, the leader in AI-powered disease detection and intelligent care coordination, has launched Viz ...

Time May 02, 2025
arrow
News | Lung Imaging

April, 15, 2025 — Optellum has entered an agreement with Bristol Myers Squibb to leverage AI in early diagnosis and ...

Time April 17, 2025
arrow
Subscribe Now